| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
VistaGen Therapeutics, Inc. is a clinical-stage biopharmaceutical entity dedicated to advancing and commercializing innovative medications for anxiety, depression, and various other disorders impacting the central nervous system (CNS). A key component of its CNS pipeline is PH94B, a fast-acting neuroactive nasal spray currently in Phase III trials for the rapid treatment of anxiety in adults experiencing social anxiety disorder. PH94B also shows potential for addressing a broader spectrum of anxiety conditions, including adjustment disorder …
Over the last 12 months, insiders at VistaGen Therapeutics, Inc. have bought $0 and sold $0 worth of VistaGen Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at VistaGen Therapeutics, Inc. have bought $9.07M and sold $106,800 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 775,756 shares for transaction amount of $17.96M was made by COMMODORE CAPITAL LP (10 percent owner) on 2023‑08‑07.
| 2023-08-07 | COMMODORE CAPITAL LP | 10 percent owner | 775,756 22.7138% | $23.15 | $17.96M | -65.44% | ||
| 2022-08-18 | GIN JERRY B | 100,000 0.0226% | $0.18 | $17,870 | -36.36% | |||
| 2022-08-17 | Singh Shawn | CHIEF EXECUTIVE OFFICER | 600,000 0.1305% | $0.17 | $103,200 | -26.32% | ||
| 2022-08-17 | Adler Reid G. | CHIEF LEGAL OFFICER | 300,000 0.0644% | $0.17 | $50,910 | -26.32% | ||
| 2022-07-12 | Sale | Venrock Healthcare Capital Partners II, L.P. | 10 percent owner | 60,000 0.0675% | $0.89 | $53,400 | -83.91% | |
| 2022-07-12 | Sale | Shah Nimish P | 60,000 0.0675% | $0.89 | $53,400 | -83.91% | ||
| 2021-09-07 | Sale | DOTSON JERROLD DUANE | VP, CFO AND SECRETARY | 30,000 0.1186% | $3.13 | $93,750 | -55.73% | |
| 2021-08-17 | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 3,750 0.0129% | $2.73 | $10,238 | -44.65% | ||
| 2020-08-21 | SAXE JON S | director | 30,000 0.0262% | $0.69 | $20,700 | +208.70% | ||
| 2019-11-20 | SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 15,000 0.0064% | $0.34 | $5,100 | +88.24% | ||
| 2019-03-14 | SAXE JON S | director | 7,920 0.0128% | $1.27 | $10,086 | -42.19% | ||
| 2019-03-13 | SAXE JON S | director | 12,080 0.0192% | $1.26 | $15,201 | -41.27% | ||
| 2017-05-31 | GIN JERRY B | director | 100,000 0.2529% | $2.00 | $200,000 | -33.86% | ||
| 2011-05-09 | Sale | JONES STEPHANIE | PRESIDENT | 4.98M – | $0 | $0 |
| COMMODORE CAPITAL LP | 10 percent owner | 1575000 3.5491% | $264,600.00 | 1 | 0 | <0.0001% |
| Singh Shawn | CHIEF EXECUTIVE OFFICER | 626234 1.4112% | $105,207.31 | 1 | 0 | |
| Adler Reid G. | CHIEF LEGAL OFFICER | 334629 0.7541% | $56,217.67 | 1 | 0 | |
| GIN JERRY B | 100000 0.2253% | $16,800.00 | 2 | 0 | <0.0001% | |
| SAXE JON S | director | 50000 0.1127% | $8,400.00 | 3 | 0 | +208.7% |
| SNODGRASS H. RALPH | PRES./CHIEF SCIENTIFIC OFFICER | 34641 0.0781% | $5,819.69 | 2 | 0 | +88.24% |
$13,664,154 | 40 | -70.35% | $7.05M | |
$29,645,465 | 28 | 8.09% | $6.48M | |
$63,749,694 | 24 | -12.24% | $6.4M | |
$287,718 | 15 | -41.45% | $5.68M | |
$812,698 | 12 | -57.09% | $7.89M |
| Increased Positions | 33 | +47.14% | 3M | +11.03% |
| Decreased Positions | 31 | -44.29% | 12M | -51.88% |
| New Positions | 15 | New | 891,415 | New |
| Sold Out Positions | 16 | Sold Out | 9M | Sold Out |
| Total Postitions | 72 | +2.86% | 14M | -40.84% |
| Janus Henderson Group Plc | $2,829.00 | 10.68% | 4.17M | +4M | New | 2025-09-30 |
| Orbimed Advisors Llc | $2,078.00 | 7.85% | 3.06M | +3M | New | 2025-09-30 |
| Tcg Crossover Management, Llc | $1,817.00 | 6.86% | 2.68M | 0 | 0% | 2025-09-30 |
| Stempoint Capital Lp | $1,690.00 | 6.38% | 2.49M | +75,431 | +3.13% | 2025-09-30 |
| Nantahala Capital Management, Llc | $1,343.00 | 5.07% | 1.98M | 0 | 0% | 2025-09-30 |
| Vanguard Group Inc | $1,146.00 | 4.33% | 1.69M | -71,907 | -4.09% | 2025-09-30 |
| Commodore Capital Lp | $1,069.00 | 4.04% | 1.57M | 0 | 0% | 2025-09-30 |
| Ikarian Capital, Llc | $422.00 | 1.59% | 620,869 | +19,166 | +3.19% | 2025-09-30 |
| Soleus Capital Management, L.P. | $373.00 | 1.41% | 550,000 | +550,000 | New | 2025-09-30 |
| Blackrock, Inc. | $287.00 | 1.09% | 423,128 | +6,239 | +1.5% | 2025-09-30 |